ArticleFrontiers in oncology2024

HER2-low non-metastatic breast cancer in Qatar-a nationwide retrospective cohort study to evaluate the response to neoadjuvant chemotherapy: a real-world analysis.

Ahmed Kardousha et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.